Hong Kong-based venture capital firm ORI Capital plans to launch a new fund to invest in Chinese healthcare start-ups, as…
Read More »Legend Biotech
Licensing deals struck by Chinese biotech start-ups with overseas partners could potentially fetch billions in revenue if their drug candidates…
Read More »